SIG
TEVA icon

Senator Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History

Senator Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-900,000
Closed -$45.2M – 70
2016
Q2 		$45.2M Sell
900,000
-1,850,000
-67% -$98.5M 0.72% 36
2016
Q1 		$147M Sell
2,750,000
-2,000,000
-42% -$117M 1.94% 24
2015
Q4 		$312M Buy
4,750,000
+1,250,000
+36% +$77.2M 3.89% 5
2015
Q3 		$198M Buy
3,500,000
+1,200,000
+52% +$77.8M 2.42% 16
2015
Q2 		$136M Buy
+2,300,000
New +$142M 1.18% 38

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Senator Investment Group's TEVA Position: Q3 2016 in Review

Senator Investment Group sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 900,000 shares — an estimated $45.2M sold.

Senator Investment Group first reported a position in TEVA in Q2 2015 and held it in 5 quarters. The position peaked at $312M in Q4 2015. 798 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Senator Investment Group reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Senator Investment Group sold 900,000 Teva Pharmaceuticals shares in Q3 2016, an estimated $45.2M.
  • Senator Investment Group first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 5 quarters.
  • Senator Investment Group's Teva Pharmaceuticals position peaked at $312M in Q4 2015.
  • 798 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Senator Investment Group's 13F filing for Q3 2016, filed 14 Nov 2016.